732 related articles for article (PubMed ID: 26985062)
1. RAS isoforms and mutations in cancer at a glance.
Hobbs GA; Der CJ; Rossman KL
J Cell Sci; 2016 Apr; 129(7):1287-92. PubMed ID: 26985062
[TBL] [Abstract][Full Text] [Related]
2. Ras protein abundance correlates with Ras isoform mutation patterns in cancer.
Hood FE; Sahraoui YM; Jenkins RE; Prior IA
Oncogene; 2023 Apr; 42(15):1224-1232. PubMed ID: 36864243
[TBL] [Abstract][Full Text] [Related]
3. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
5. Differential functions of the KRAS splice variants.
Kochen Rossi J; Nuevo-Tapioles C; Philips MR
Biochem Soc Trans; 2023 Jun; 51(3):1191-1199. PubMed ID: 37222266
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
[TBL] [Abstract][Full Text] [Related]
7. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior.
Goswami D; Chen D; Yang Y; Gudla PR; Columbus J; Worthy K; Rigby M; Wheeler M; Mukhopadhyay S; Powell K; Burgan W; Wall V; Esposito D; Simanshu DK; Lightstone FC; Nissley DV; McCormick F; Turbyville T
Elife; 2020 Jan; 9():. PubMed ID: 31958057
[TBL] [Abstract][Full Text] [Related]
8. A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions.
Miller SP; Maio G; Zhang X; Badillo Soto FS; Zhu J; Ramirez SZ; Lin H
Mol Cell Proteomics; 2022 Aug; 21(8):100268. PubMed ID: 35839996
[TBL] [Abstract][Full Text] [Related]
9. A model for RAS mutation patterns in cancers: finding the sweet spot.
Li S; Balmain A; Counter CM
Nat Rev Cancer; 2018 Dec; 18(12):767-777. PubMed ID: 30420765
[TBL] [Abstract][Full Text] [Related]
10. Origin and Evolution of RAS Membrane Targeting.
García-España A; Philips MR
Oncogene; 2023 May; 42(21):1741-1750. PubMed ID: 37031342
[TBL] [Abstract][Full Text] [Related]
11. Decoding RAS isoform and codon-specific signalling.
Newlaczyl AU; Hood FE; Coulson JM; Prior IA
Biochem Soc Trans; 2014 Aug; 42(4):742-6. PubMed ID: 25109951
[TBL] [Abstract][Full Text] [Related]
12. The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer.
Ouerhani S; Elgaaied AB
Cancer Biomark; 2011-2012; 10(6):259-66. PubMed ID: 22820081
[TBL] [Abstract][Full Text] [Related]
13. The effects of mutant Ras proteins on the cell signalome.
Takács T; Kudlik G; Kurilla A; Szeder B; Buday L; Vas V
Cancer Metastasis Rev; 2020 Dec; 39(4):1051-1065. PubMed ID: 32648136
[TBL] [Abstract][Full Text] [Related]
14. Ras Isoforms from Lab Benches to Lives-What Are We Missing and How Far Are We?
Nair A; Kubatzky KF; Saha B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204435
[TBL] [Abstract][Full Text] [Related]
15. The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants.
Parker JA; Mattos C
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29038336
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations.
Hunter JC; Manandhar A; Carrasco MA; Gurbani D; Gondi S; Westover KD
Mol Cancer Res; 2015 Sep; 13(9):1325-35. PubMed ID: 26037647
[TBL] [Abstract][Full Text] [Related]
17. Improving Prospects for Targeting RAS.
Singh H; Longo DL; Chabner BA
J Clin Oncol; 2015 Nov; 33(31):3650-9. PubMed ID: 26371146
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties.
Whitley MJ; Tran TH; Rigby M; Yi M; Dharmaiah S; Waybright TJ; Ramakrishnan N; Perkins S; Taylor T; Messing S; Esposito D; Nissley DV; McCormick F; Stephen AG; Turbyville T; Cornilescu G; Simanshu DK
Sci Adv; 2024 Feb; 10(7):eadj4137. PubMed ID: 38354232
[No Abstract] [Full Text] [Related]
19. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.
García-Cruz R; Camats M; Calin GA; Liu CG; Volinia S; Taccioli C; Croce CM; Bach-Elias M
BMC Med Genet; 2015 Jul; 16():46. PubMed ID: 26138095
[TBL] [Abstract][Full Text] [Related]
20. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
